The Chinese medicine publicity column in COVID-19 has Chinese medicine content. Novel coronavirus, for example, is a newly discovered viral pneumonia in China, which is caused by coronavirus infection. Highly contagious, people are generally susceptible. The incubation period is also relatively long, belonging to class B infectious diseases. If it is managed according to Class A, it will cause symptoms such as fever, fatigue and dry cough. There will also be severe respiratory distress syndrome and metabolic acidosis. Lianhua Qingwen Capsule, Jinhua Qinggan Granule, antivirus granule and Shuanghuanglian oral liquid belong to Chinese patent medicines, which have the functions of moistening lung and relieving cough, clearing away heat and resolving phlegm, cooling blood and promoting blood circulation, and have the function of adjuvant treatment of COVID-19.